Surgery Partners Inc (NASDAQ: SGRY) on Monday, soared 3.52% from the previous trading day, before settling in for the closing price of $30.36. Within the past 52 weeks, SGRY’s price has moved between $22.25 and $36.92.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 9.35%. The company achieved an average annual earnings per share of 3.19%. With a float of $71.06 million, this company’s outstanding shares have now reached $126.59 million.
Considering the fact that the conglomerate employs 13500 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 20.57%, operating margin of 14.42%, and the pretax margin is 5.11%.
Surgery Partners Inc (SGRY) Insider Activity
Observing investor behavior towards Medical Care Facilities industry stocks is more important than anything else. The insider ownership of Surgery Partners Inc is 44.10%, while institutional ownership is 69.71%. The most recent insider transaction that took place on Sep 05 ’24, was worth 283,652. Before that another transaction happened on Sep 04 ’24, when Company’s National Group President sold 6,325 for $31.11, making the entire transaction worth $196,742. This insider now owns 48,236 shares in total.
Surgery Partners Inc (SGRY) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 3.19% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 46.10% during the next five years compared to 54.69% growth over the previous five years of trading.
Surgery Partners Inc (NASDAQ: SGRY) Trading Performance Indicators
Surgery Partners Inc (SGRY) is currently performing well based on its current performance indicators. A quick ratio of 1.69 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.38. Likewise, its price to free cash flow for the trailing twelve months is 19.54.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.27, a number that is poised to hit 0.25 in the next quarter and is forecasted to reach 1.27 in one year’s time.
Technical Analysis of Surgery Partners Inc (SGRY)
Compared to the last year’s volume of 0.93 million, its volume of 1.08 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 81.17%. Additionally, its Average True Range was 1.17.
During the past 100 days, Surgery Partners Inc’s (SGRY) raw stochastic average was set at 78.33%, which indicates a significant increase from 77.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.54% in the past 14 days, which was lower than the 49.35% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $31.03, while its 200-day Moving Average is $28.82. Nevertheless, the first resistance level for the watch stands at $32.07 in the near term. At $32.70, the stock is likely to face the second major resistance level. The third major resistance level sits at $33.52. If the price goes on to break the first support level at $30.62, it is likely to go to the next support level at $29.80. Should the price break the second support level, the third support level stands at $29.17.
Surgery Partners Inc (NASDAQ: SGRY) Key Stats
Market capitalization of the company is 3.99 billion based on 127,124K outstanding shares. Right now, sales total 2,743 M and income totals -11,900 K. The company made 762,100 K in profit during its latest quarter, and -15,500 K in sales during its previous quarter.
